Literature DB >> 22531957

The prevalence of detrusor overactivity amongst patients with symptoms of overactive bladder: a retrospective cohort study.

P Diamond1, S Hassonah, M Alarab, D Lovatsis, H P Drutz.   

Abstract

INTRODUCTION AND HYPOTHESIS: Overactive bladder (OAB) is a symptom-based condition consisting of urgency, with or without incontinence, usually with frequency and nocturia. There are many potential causes of OAB, yet many patients are prescribed anticholinergic medications empirically. This study aimed to determine what proportion of patients presenting for urogynecologic assessment with symptoms of OAB had urodynamic detrusor overactivity (DO).
METHODS: Retrospective chart review was performed for 220 consecutive patient referrals. Demographic data, physical exam information, and urodynamic results were collected. The t test and Fisher's exact test were used for statistical analyses.
RESULTS: The prevalence of DO was 11.8 % in this population. Urogenital atrophy and incomplete emptying were more common. Patients with DO were older and more often menopausal than those without DO. Significant prolapse was a common finding amongst patients with OAB symptoms.
CONCLUSIONS: Patients with symptoms of OAB should undergo pelvic examination and assessment of post-void residuals before being initiated on anticholinergic medication.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22531957     DOI: 10.1007/s00192-012-1781-4

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  15 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  The pathophysiology of urinary incontinence among institutionalized elderly persons.

Authors:  N M Resnick; S V Yalla; E Laurino
Journal:  N Engl J Med       Date:  1989-01-05       Impact factor: 91.245

3.  Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

Authors:  Debra E Irwin; Ian Milsom; Steinar Hunskaar; Kate Reilly; Zoe Kopp; Sender Herschorn; Karin Coyne; Con Kelleher; Christian Hampel; Walter Artibani; Paul Abrams
Journal:  Eur Urol       Date:  2006-10-02       Impact factor: 20.096

Review 4.  Pelvic organ prolapse and overactive bladder.

Authors:  T A de Boer; S Salvatore; L Cardozo; C Chapple; C Kelleher; P van Kerrebroeck; M G Kirby; H Koelbl; M Espuna-Pons; I Milsom; A Tubaro; A Wagg; M E Vierhout
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

Review 5.  The role of estrogen supplementation in lower urinary tract dysfunction.

Authors:  A Hextall; L Cardozo
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2001

Review 6.  Detrusor overactivity: an overview.

Authors:  Kiran Ashok; Alex Wang
Journal:  Arch Gynecol Obstet       Date:  2010-02-27       Impact factor: 2.344

7.  Overactive bladder symptoms: do we need urodynamics?

Authors:  G Alessandro Digesu; Vik Khullar; Linda Cardozo; Stefano Salvatore
Journal:  Neurourol Urodyn       Date:  2003       Impact factor: 2.696

Review 8.  Urogenital atrophy.

Authors:  J Calleja-Agius; M P Brincat
Journal:  Climacteric       Date:  2009-08       Impact factor: 3.005

9.  Prevalence and burden of overactive bladder in the United States.

Authors:  W F Stewart; J B Van Rooyen; G W Cundiff; P Abrams; A R Herzog; R Corey; T L Hunt; A J Wein
Journal:  World J Urol       Date:  2002-11-15       Impact factor: 4.226

10.  Overactive bladder: the importance of tailoring treatment to the individual patient.

Authors:  Harold P Drutz
Journal:  J Multidiscip Healthc       Date:  2011-07-22
View more
  6 in total

1.  The prevalence of detrusor overactivity amongst patients with symptoms of overactive bladder: a retrospective cohort study. Comment.

Authors:  Fulya Dökmeci; Serife Esra Cetinkaya
Journal:  Int Urogynecol J       Date:  2013-05       Impact factor: 2.894

2.  Is it possible to cure the symptoms of the overactive bladder in women?

Authors:  Jan Krhut; Alois Martan; Roman Zachoval; Tomas Hanus; Lukas Horcicka; Kamil Svabík; Peter Zvara
Journal:  Int Urol Nephrol       Date:  2018-01-10       Impact factor: 2.370

3.  Caffeine as a Probable Factor for Increased Risk of OAB Development in Elderly People.

Authors:  Kirill V Kosilov; Sergay A Loparev; Marina A Ivanovskaya; Liliya V Kosilova
Journal:  Curr Urol       Date:  2016-09-20

4.  Changes in nerve growth factor level and symptom severity following antibiotic treatment for refractory overactive bladder.

Authors:  G Vijaya; R Cartwright; A Derpapas; P Gallo; R Fernando; V Khullar
Journal:  Int Urogynecol J       Date:  2013-02-02       Impact factor: 2.894

5.  Prevalence of detrusor overactivity among patients with symptoms of overactive bladder: a retrospective cohort study. Reply.

Authors:  P Diamond; S Hassonah; D Lovatsis; H P Drutz
Journal:  Int Urogynecol J       Date:  2013-05       Impact factor: 2.894

6.  The Value of Urodynamic Study for Diagnosing the Causes of Lower Urinary Tract Symptoms in Male Patients: A Study From Iran.

Authors:  Fatemeh Heydari; Bentolhoda Rezadoust; Shahin Abbaszade; Eidi Jahan Afrouz; Alireza Ghadian
Journal:  Nephrourol Mon       Date:  2016-05-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.